To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Talar Osteochondral lesions: Adjunct hyaluronan injection improves microfracture outcomes

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
April 2013

Talar Osteochondral lesions: Adjunct hyaluronan injection improves microfracture outcomes

Vol: 2| Issue: 3| Number:193| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Treatment of osteochondral lesions of the talus with microfracture technique and postoperative hyaluronan injection

Knee Surg Sports Traumatol Arthrosc. 2012 Jul;20(7):1398-403. doi: 10.1007/s00167-011-1856-7. Epub 2011 Dec 29

Contributing Authors:
MN Doral O Bilge G Batmaz G Donmez E Turhan M Demirel OA Atay A Uzumcugil K Atesok D Kaya

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

57 patients with osteochondral lesions of the talus undergoing arthroscopic debridement and microfracture were randomized to assess the efficacy of an adjunct hyaluronan injection. Patients received either an intra-articular hyaluronan injection or no injection following arthroscopic debridement and microfracture treatment. Results from the 2 year follow-up demonstrated that both groups provided a...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue